Certolizumab pegol: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "* TNF-α inhibitor * Recombinant humanized Fab' antibody fragment that is specific to TNF-α, conjugated to PEG * Indications include..." |
(No difference)
|
Latest revision as of 11:12, 17 March 2022
- TNF-α inhibitor
- Recombinant humanized Fab' antibody fragment that is specific to TNF-α, conjugated to PEG
- Indications include Crohn disease and RA
- Infectious complications include TB and other infections similar to other TNF-α inhibitors
